Racial differences in low-density lipoprotein particle size in families at high risk for premature coronary heart disease

Ethnicity and Disease

Volumn 11, Issue 2, 2001, Pages 325-337

  Kral, Brian G ^a   Becker, Lewis C ^a,c   Yook, Raphael M ^a   Blumenthal, Roger S ^a   Kwiterovich Jr , Peter O ^a   Otvos, James D ^b   Becker, Diane M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Apolipoproteins; Coronary Disease; Lipids; Lipoproteins; Risk Factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD; CAUCASIAN; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; NEGRO; PARTICLE SIZE; STATISTICAL MODEL; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, LDL; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MARYLAND; MIDDLE AGED; PARTICLE SIZE;

EID: 0035293758     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. National Cholesterol Education Program Working Group on Lipoprotein Measurement. Recommendations on lipoprotein measurement. National Cholesterol Education Program. Bethesda, Md: National Institute of Health; 1995. NIH Publication No. 95-3044.
2. Superko HR, Krauss RM. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation. 1994;90:1056-1069.
3. Kwiterovich PO Jr. State-of-the-art update and review: clinical trials of lipid-lowering agents. Am J Cardiol. 1998;82(12A):3U-17U.
4. Genest JJ, McNamara JR, Ordovas JM, et al. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormality in men with premature coronary heart disease. J Am Coll Cardiol. 1992;19:792-802.
5. Sniderman AD, Pedersen T, Kjekshus J. Putting low-density lipoproteins at center stage in atherogenesis. Am J Cardiol. 1997;79:64-67.
6. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low-density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
7. Fisher WR. Heterogeneity of plasma low-density lipoproteins manifestations of the physiologic phenomenon in man. Metabolism. 1983;32:283-291.
8. Chapman MJ, Laplaud PM, Luc G, et al. Further resolution of the low-density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res. 1988;29:442-458.
9. Nigon F, Lesnik P, Rouis M, Chapman J. Discrete subspecies of human low-density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J. Lipid Res. 1991;32:1741-1753.
10. Chait A, Brazg RL, Tribble DL. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med. 1993; 94:350-356.
11. Hurt-Camejo E, Camejo G, Rosengreen B, Lopez F, Wilklund O, Bondjers G. Differential uptake of proteoglycan-selected subfractions of low-density lipoprotein by human macrophages. J Lipid Res. 1990;31:1387-1398.
12. Coresh J, Kwiterovich PO, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 1993; 34:1687-1697.
13. Austin MA, Breslow JL, Hennekins CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
14. Campos H, Genest JJ, Blijlevens E, et al. Low-density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
15. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276:875-881.
16. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
17. Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation. 1997;95:69-75.
18. Krauss RM, Lindgren FT, Ray RM. Interrelationships among subgroups of serum lipoproteins in normal human subjects. Clin Chim Acta. 1980; 104:275-290.
19. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ. Effect of gender, age, and lipid status on low-density lipoprotein subtraction distribution: results from the Framingham Offspring Study. Arteriosclerosis. 1987;7: 483-490.
20. McNamara JR, Jenner JL, Zhengling L, Wilson P, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb. 1992;12:1284-1290.
21. Katzel LI, Krauss RM, Goldberg AP. Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles. Arterioscler Thromb. 1994;14:1121-1128.
22. Reaven GM, Chen Y-DI, Jeppesen J, Maheux PA, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low-density lipoprotein particles. J Clin Invest. 1993;92:141-146.
23. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease. Clin Chem. 1988; 34(suppl):B78-B83.
24. Otvos J, Jeyarajah E, Bennett D. A spectroscopic approach to lipoprotein subclass analysis. J Clin Ligand Assay. 1996;19:184-189.
25. Teng B, Thompson GR, Sniderman AD, Forte TM, Krauss RM, Kwiterovich PO Jr. Composition and distribution of low-density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci USA. 1983;80:6662-6666.
26. Kwiterovich PO Jr. Prevention of coronary disease starting in childhood: what risk factors should be identified and treated? Coron Artery Dis. 1993;4: 611-630.
27. Kwiterovich PO Jr, Motevalli M, Miller M, et al. Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III. Clin Chem. 1991;37:317-326.
28. Packard CJ, Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol. 1997;17:3542-3556.
29. Elovson J, Chatterton JE, Bell FT, et al. Plasma VLDL contain a single molecule of apolipoprotein B. J Lipid Res. 1988;29:1461-1473.
30. Campos H, Blijlevens E, McNamara JR, et al. Particle size distribution: results from the Framingham Offspring Study. Arterioscler Thromb. 1992; 12:1410-1419.
31. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human low-density (β) lipoprotein]. Proc Natl Acad Sci USA. 1980;77:604-608.
32. Morrison JA, deGroot I, Kelly KA, et al. Black-White differences in plasma lipids and lipoproteins in adults: The Cincinnati Lipid Research Clinic Population Study. Prev Med. 1979;8:34-39.
33. Tyroler HA, Glueck CJ, Christensen B, Kwiterovich PO. Plasma high-density lipoprotein cholesterol comparisons in Black and White populations. Circulation. 1980;62(suppl 4):99-107.
34. Cowie CC, Harris MI, Silverman RE, Johnson EW, Rust KF. Effect of multiple risk factors on differences between Blacks and Whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States. Am J Epidemiol. 1993; 137:719-732.
35. Molitch M. Changing those grim statistics. Clin Diabetes. 1991;9:50-51.
36. Kuczmarski MF, Moshfegh A, Briefel R. Update on nutrition monitoring activities in the United States. J Am Diet Assoc. 1994;94:753-760.
37. Jamerson KA. Prevalence of complications and response to different treatments of hypertension in African Americans and White Americans in the US. Clin Exp Hypertens. 1993;15:979-995.
38. Saunders E. Hypertension in Blacks. Med Clin North Am. 1987;71:1013-1029.
39. Neaton JD, Kuller LH, Wentworth D. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among Black and White males followed up for five years. Am Heart J. 1984;108:759-769.
40. Keil JE, Sutherland SE, Hames CG, et al. Coronary disease mortality and risk factors in Black and White men. Arch Intern Med. 1995;155:1521-1527.
41. Becker DM, Becker LC, Pearson TA, Fintel DJ, Levine DM, Kwiterovich PO. Risk factors in siblings of people with premature coronary heart disease. J Am Coll Cardiol. 1988;12:1273-1280.
42. Becker DM, Rook RM, Moy TF, Blumenthal RS, Becker LC. Markedly high prevalence of coronary risk factors in apparently healthy African-American and White siblings of persons with premature coronary heart disease. Am J Cardiol. 1998;82: 1046-1051.
43. Blumenthal RS, Becker DM, Moy TF, Coresh J, Wilder LB, Becker LC. Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population. Circulation. 1996;93:915-923.
44. Expert Panel on the Identification Evaluation and Treatment of Overweight and Obesity in Adults. Clinical guidelines for the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Preprint. Bethesda, Md: NIH/NHLBI; 1998.
45. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: the fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med. 1993; 153:154-183.
46. Pesce AJ, Kaplan LA. Methods in Clinical Chemistry. St. Louis, Mo: Mosby; 1987:126.
47. Bachorik PS, Cloey TA, Finney CA, Lowry DR, Becker DM. Lipoprotein-cholesterol analysis during screening: accuracy and reliability. Ann Intern Med. 1991;114:741-747.
48. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentrations of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18: 499-502.
49. Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL, Albers JJ, Marcovina SM. Measurement of apolipoproteins A-I and B during the National Health and Nutrition Examination Survey (NHA-NES) III. Clin Chem. 1994;40:1915-1920.
50. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein (a) kringle 4 domains on immunochemical measurements of lipoprotein (a). Clin Chem. 1995; 41:246-255.
51. Kwiterovich PO Jr, White S, Forte T, Bachorik PS, Smith H, Sniderman A. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Atherosclerosis. 1987;7:211-225.
52. Beaty TH, Kwiterovich PO Jr, Khoury MJ, et al. Genetic analysis of plasma sitosterol, apoprotein B and lipoproteins in a large Amish pedigree with sitosterolemia. Am J Hum Genet. 1986;38:492-504.
53. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease. Circulation. 1990;82:495-506.
54. Austin MA, Mykkanen L, Kuusiste J, et al. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation. 1995;92:1770-1778.
55. Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ. Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low-density lipoproteins. J Lipid Res. 1992;33: 1551-1561.
56. SAS Institute. SAS User's Guide: Basics. Cary, NC: SAS Institute Inc; 1985.
57. Fless GM, Zum Mallen ME, Scanu AM. Physiochemical properties of apolipoprotein (a) and lipoprotein (a) derived from the dissociation of human plasma lipoprotein (a). J Biol Chem. 1986; 261:8712-8718.
58. Austin MA, King M, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet. 1988;43:838-846.
59. Rotter JI, Bu X, Cantor RM, et al. Multi-locus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet. 1996;58:585-594.
60. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 1991;88:2059-2066.
61. Cardiovascular and Cerebrovascular Diseases in Black Americans. Cardiovascular and Cerebrovascular Disease, Part I. Washington, DC: United States Department of Health and Human Services; January 1986:3-54. Report of the Secretary's Task Force on Black and Minority Health; vol 4.
62. Cardiovascular and Cerebrovascular Diseases in Black Americans. Cardiovascular and Cerebrovascular Disease, Part I. Washington, DC: United States Department of Health and Human Services; January 1986:3-54. Report of the Secretary's Task Force on Black and Minority Health; vol 4.
63. Peniston RL, Adams-Campbell L, Fletcher JW, et al. Coronary arteriographic findings in Black patients and risk markers for coronary artery disease. Am Heart J. 1994;127:552-559.
64. Maynard C, Fisher LD, Passamani ER, Pullum T. Blacks in the Coronary Artery Surgery Study: risk factors and coronary artery disease. Circulation. 1986;74:64-71.
65. Simmons BE, Castaner A, Campo A, Ferlinz J, Mar M, Cooper R. Coronary artery disease in Blacks of lower socioeconomic status: angiographic findings from the Cook County Hospital Heart Disease Registry. Am Heart J. 1988;116: 90-97.
66. McDonough JR, Hames CG, Stulb SC, Garrison GE. Coronary heart disease among Negroes and Whites in Evans County, Georgia. J Chronic Dis. 1965;18:443-468.
67. Keil JE, Loadholt CB, Weinrich MC, Sandifer SH, Boyle E Jr. Incidence of coronary heart disease in Blacks in Charleston, South Carolina. Am Heart J. 1984;108:779-786.
68. Islam S, Gutin B, Manos T, Smith C, Treiber F. Low-density lipoprotein cholesterol/apolipoprotein B-100 ratio: interaction of family history of premature atherosclerotic coronary artery disease with race and gender in 7 to 11 year olds. Pediatrics. 1994;94:494-499.
69. Srinivasan SR, Wattigney W, Webber LS, Berenson GS. Relation of cholesterol to apoB in low-density lipoproteins in children: the Bogalusa Heart Study. Arteriosclerosis. 1989;9:493-500.
70. Dreon DM, Fernstrom H, Miller B, Krauss RM. Low-density lipoprotein subclass patterns and lipoprotein response to a reduced fat diet in men. FASEB J. 1994;8:121-126.
71. Watts GF, Mandalia S, Brunt JN, Slavin BM, Coltart DJ, Lewis B. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism. 1993;42:1461-1467.
72. Hodis HN, Mack WJ, Azen SP, et al. Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin in the Monitored Atherosclerosis Regression Study. Circulation. 1994;90:42-49.